ONL Therapeutics Funding: $148M Raised, Series B (2021)
ONL Therapeutics is a Biotech company based in Ann Arbor, Michigan. It has raised $148M in total funding. Latest round: Series B.
ONL Therapeutics funding overview
ONL Therapeutics is a Biotech company based in Ann Arbor, Michigan. ONL Therapeutics has raised $148M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for ONL Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Johnson & Johnson Innovative Medicine (JJDC), Bios Partners, Novartis Venture Fund, Visionary Ventures, InFocus Capital Partners, Exite Ventures. 6 distinct backers are named across the disclosed rounds.
ONL Therapeutics at a glance
Total raised
$148M
Latest round
Series B
Latest round date
January 2021
Industry
Biotech
Headquarters
Ann Arbor, Michigan
Notable investors
Johnson & Johnson Innovative Medicine (JJDC), Bios Partners, Novartis Venture Fund, Visionary Ventures, InFocus Capital Partners, Exite Ventures
Frequently asked about ONL Therapeutics funding
How much has ONL Therapeutics raised?
ONL Therapeutics has raised $148M in total disclosed funding across the rounds on record.
Who has invested in ONL Therapeutics?
Johnson & Johnson Innovative Medicine (JJDC), Bios Partners, Novartis Venture Fund, Visionary Ventures, InFocus Capital Partners, Exite Ventures are named among the investors backing ONL Therapeutics.
What was the latest ONL Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2021.
Where is ONL Therapeutics based?
ONL Therapeutics is based in Ann Arbor, Michigan.
What sector does ONL Therapeutics operate in?
ONL Therapeutics is tracked under Biotech from Ann Arbor, Michigan, with $148M in disclosed funding.
When did ONL Therapeutics last raise?
The last disclosed ONL Therapeutics round closed in January 2021 at Series B.
Totals shown for ONL Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Ann Arbor and the investors behind them below.
